I now have comprehensive material. Let me compile the full answer:
Mesenteric Ischemia
Mesenteric ischemia refers to ischemia of the small intestine due to compromise of its blood supply (primarily the superior mesenteric artery, SMA). It is distinct from ischemic colitis (which involves the large intestine). The two broad presentations are acute mesenteric ischemia (AMI) and chronic mesenteric ischemia (CMI).
1. Classification and Pathophysiology
Acute Mesenteric Ischemia (AMI)
Four distinct mechanisms lead to AMI:
| Cause | Approximate Frequency |
|---|
| SMA embolus (SMAE) | 26-45% |
| Mesenteric arterial occlusive disease / thrombosis (MAOD/SMAT) | 25-68% |
| Non-occlusive mesenteric ischemia (NOMI) | 10-20% |
| Mesenteric venous thrombosis (MVT) | 5-10% |
| Focal segmental ischemia | ~5% |
Arterial Embolus: Most emboli arise from cardiac sources - left atrial/ventricular thrombi (especially in atrial fibrillation) or valvular lesions. Up to 95% of AMI emboli patients have documented cardiac disease. The SMA is preferentially affected because of its large diameter and narrow takeoff angle from the aorta. Emboli lodge at branch points, typically distal to the origin of the middle colic artery (mid-to-distal SMA).
Arterial Thrombosis: Typically affects older patients with widespread atherosclerosis. Acute thrombosis superimposes on pre-existing stenotic plaques at the proximal SMA, near its origin. Associated with coronary artery disease, cerebrovascular disease, and peripheral artery disease. Less common causes include antiphospholipid syndrome, vasculitis (Behçet disease), and thrombophilias.
NOMI (Non-occlusive mesenteric ischemia): Results from mesenteric vasospasm without anatomical occlusion. Classic in critically ill patients on vasopressors (phenylephrine, norepinephrine), in heart failure, hypovolemia, or sepsis. Pain may be masked by the precipitating illness.
Mesenteric Venous Thrombosis (MVT): Accounts for 5-15% of AMI; 95% involves the superior mesenteric vein. Classified as primary (no identifiable cause) or secondary (hypercoagulable states: Factor V Leiden, antiphospholipid antibody, oral contraceptive use, malignancy, portal hypertension). Younger patients are more frequently affected (e.g., women with thrombophilia on OCPs).
Critical timeline: AMI can cause intestinal mucosal sloughing within 3 hours of onset and full-thickness infarction by 6 hours - Schwartz's Principles of Surgery, 11th ed.
Chronic Mesenteric Ischemia (CMI)
- Results from atherosclerotic stenosis of the main splanchnic arteries (celiac, SMA, IMA)
- Requires at least 2 of 3 major vessels to be occluded/severely stenosed for symptoms (collaterals compensate for single-vessel disease)
- Rarely leads to infarction because collaterals develop slowly
- Chronic MVT can involve the portal/splenic veins, causing portal hypertension
2. Clinical Features
Acute Mesenteric Ischemia
Classic presentation:
- Severe abdominal pain out of proportion to physical findings - the hallmark (though seen in only ~29% by modern data, as NOMI/MVT present more indolently)
- Pain is typically colicky, worst in the mid-abdomen
- Nausea, vomiting, diarrhea
- Forceful bowel evacuation early in SMAE
- Rectal bleeding (~13-16%)
- Delirium (especially in elderly)
Late signs (bowel infarction):
- Fever, tachycardia, hypotension
- Abdominal distension (first sign of infarction, ~25%)
- Decreased/absent bowel sounds
- Peritonitis: rigidity, rebound tenderness, guarding
Risk factors: Age >50, atrial fibrillation, recent MI, heart failure, hypotension, vasopressor use, cocaine use, thrombophilia, vasoactive medications (triptans, amphetamines).
Chronic Mesenteric Ischemia
- Postprandial abdominal pain (intestinal angina) - occurs 15-30 min after eating, due to "vascular steal"
- Food fear - patients avoid eating to prevent pain
- Weight loss - often misdiagnosed as malignancy
- Often symptomatic for months before correct diagnosis
3. Diagnosis
Laboratory
- Leukocytosis (WBC >15,000) - common but nonspecific; normal WBC does not exclude early AMI
- Elevated serum lactate - nonspecific; elevated in infarction but not early ischemia
- Elevated alkaline phosphatase - released from ischemic intestinal tissue
- D-dimer - elevated in thrombotic causes (sensitive but nonspecific)
- Metabolic acidosis, elevated amylase, LDH - late findings
- Ischemia-modified albumin and procalcitonin may be helpful markers per systematic review
Imaging
Plain X-ray (AXR/upright CXR):
- Early: nonspecific - bowel dilation, thickened folds, air-fluid levels
- Late: "Thumbprinting" (submucosal edema), pneumatosis intestinalis (intramural gas from gas-forming bacteria - sign of necrosis), portal venous gas, pneumoperitoneum
CT Angiography (CTA): The study of choice
- Sensitivity ~89%, specificity ~99.5%
- Identifies: bowel wall thickening, pneumatosis intestinalis, portal venous gas, mesenteric fat stranding, segmental ischemia in vascular distribution
- Identifies the underlying cause (embolus vs. thrombosis) and location for procedural planning
- Best for occlusive disease; less reliable for NOMI
Conventional Angiography:
- Supplanted by CTA but still used when CTA is equivocal
- Required for NOMI diagnosis (papaverine infusion)
- Allows simultaneous therapeutic intervention
MR Angiography: Accurate but time-consuming; limits its role in emergencies.
CT findings of advanced AMI:
Axial CT showing pneumatosis intestinalis (intramural gas) - a late sign of ischemic necrosis mandating urgent laparotomy
Coronal CT showing bowel wall thickening and mesenteric fat stranding in mesenteric venous ischemia
4. Management
General Principles (AMI)
Mortality is 70-80% if diagnosis is made after infarction vs. significantly lower with pre-infarction diagnosis. The key is early, aggressive intervention.
- Resuscitation: IV fluids, broad-spectrum antibiotics (for bacterial translocation), correct hemodynamic instability
- Anticoagulation: Heparin for thrombotic/embolic causes (reduces clot propagation)
- Avoid vasoconstrictors if possible; treat the underlying cause of hypoperfusion
- Nasogastric decompression
Surgical vs. Endovascular Revascularization
A
2024 systematic review and meta-analysis (PMID 39069018) compared endovascular vs. open revascularization as first strategy for arterial AMI, and a
2025 systematic review (PMID 40275298) assessed overall AMI management in adults.
By mechanism:
| Cause | Primary Treatment |
|---|
| SMAE (embolus) | Endovascular (catheter-directed thrombolysis/thrombectomy) or surgical embolectomy; exploratory laparotomy if signs of peritonitis |
| SMAT/MAOD (thrombosis) | Endovascular angioplasty + stenting (preferred first line) or surgical bypass (aortomesenteric bypass); bowel resection if necrosis |
| NOMI | Treat underlying cause (correct hypotension/hypovolemia); intra-arterial papaverine infusion via selective angiography; laparotomy only if peritonitis |
| MVT | Anticoagulation (heparin then warfarin/LMWH/DOACs); thrombolysis in severe cases; surgical thrombectomy rarely needed |
Exploratory laparotomy is mandatory when:
- Peritonitis present
- Pneumatosis intestinalis or portal venous gas on CT (signs of bowel necrosis)
- Failure of endovascular therapy
- To assess bowel viability after revascularization ("second look" laparotomy at 24-48 hours is standard practice)
Chronic Mesenteric Ischemia
A
2026 meta-analysis (PMID 40257244) compared percutaneous endovascular vs. open surgical treatment for CMI.
- Endovascular (angioplasty + stenting): First-line preferred approach; lower peri-operative morbidity and mortality; higher re-stenosis rate long-term
- Open surgical bypass (aortomesenteric bypass): More durable; reserved for patients with complex anatomy or endovascular failure
- Medical management alone is not definitive
5. Prognosis
- AMI mortality: up to 70-80% - one of the highest mortality rates of any abdominal emergency
- If revascularization is achieved before bowel infarction, mortality drops substantially
- MVT has the most favorable prognosis among AMI subtypes due to its more indolent course
- Incidence is rising due to aging populations, more patients surviving critical illness in ICUs, and increased recognition
Sources:
- Schwartz's Principles of Surgery, 11th ed. - classification, pathophysiology, clinical features
- Sleisenger & Fordtran's Gastrointestinal and Liver Disease - frequencies, clinical features, diagnosis, treatment algorithm
- Frameworks for Internal Medicine - diagnostic approach, imaging roles
- Recent meta-analyses: PMID 39069018 (endovascular vs open, 2024), PMID 40275298 (AMI management, 2025), PMID 40257244 (CMI treatment, 2026)